Healthcare >> Analyst Interviews >> June 7, 2001

Platform Technology Classes: Ajay Bansal – Mehta Partners

AJAY BANSAL is a Team Member at Mehta Partners. A seasoned industry manager, he most recently worked with Arthur D. Little's pharmaceutical consulting group and, prior to that, at Novartis, US and Switzerland. Mr. Bansal served as Executive Director, Strategy and Special Projects, in Ciba-Geigy's pharma division and holds Master's of Science degrees in Management from Kellogg Graduate School of Management and in Engineering and Operations Research from Northwestern University. He was a significant participant in the Ciba-Chiron partnership and has extensive consulting experience with Arthur D. Little and McKinsey & Company. Mr. Bansal is proficient in German. Profile
TWST: Give us an overview of the main platform technology classes that

investors are looking at these days for biotechnology.

Mr. Bansal: The technology that really caught people's eyes over